Displaying 1 - 5 of 9
Author:Querol, Luis Lewis, Richard Hartung, Hans-Peter Van Doorn, Pieter Wallstroem, Erik Luo, Xiaodong Alonso Alonso, Miguel Atassi, Nazem Hughes, Richard
Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches
Topic:Neuromuscular and Clinical Neurophysiology (EMG)
Program Number:S15.008
Author Institution:Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Cedars Sinai Medical Center, Los Angeles, CA Heinrich Heine University , Dusseldorf, Germany Erasmus MC, University Medical Center, Rotterdam, Netherlands Sanofi R&D, Neurology Development, Cambridge, MA Sanofi R&D, Biostatistics and Programming, Bridgewater, NJ UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
Author:Steinman, Lawrence Selmaj, Krzysztof Comi, Giancarlo Bar-Or, Amit Arnold, Douglas Hartung, Hans-Peter Montalban, Xavier Havrdova, Eva Sheffield, James Cheng, Chun-Yen Reardon, Jennifer Riolo, Jon Deboer, Erik Kappos, Ludwig Cohen, Jeffrey Cree, Bruce
Session Name:P2: Multiple Sclerosis: Clinical Practice and Decision Making 2
Topic:Multiple Sclerosis
Program Number:P2.007
Author Institution:Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, Stanford, CA Center for Neurology, Lódz, Poland, and Collegium Medicum, Department of Neurology, University of Warmia and Mazury, Olsztyn, Poland, Lodz, Poland Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montreal, QC, Canada Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany Brain and Mind Centre, University of Sydney, Australia Department of Neurology, Medical University of Vienna, Austria and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic, Prague, Czech Republic Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA
Author:Filippi, Massimo Riolo, Jon Cohen, Jeffrey Hartung, Hans-Peter Montalban, Xavier Meuth, Sven Freeman, Leorah Chitnis, Tanuja Granziera, Cristina Deboer, Erik Cheng, Chun-Yen Reardon, Jennifer Pachai, Chahin Sheffield, James Cree, Bruce Kappos, Ludwig
Session Name:P6: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 2
Topic:Multiple Sclerosis
Program Number:P6.014
Author Institution:Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy, Milan, Italy Bristol Myers Squibb, Princeton, New Jersey, USA, Princeton, NJ Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany Brain and Mind Centre, University of Sydney, Sydney, Australia Department of Neurology, Medical University of Vienna, Vienna, Austria and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Duesseldorf, Germany Dell Medical School, The University of Texas at Austin, Austin, Texas, USA, Austin, TX Brigham and Women’s Hospital, and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, Boston, MA Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland Department of Neurology, University Hospital Basel, Switzerland Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Bristol Myers Squibb, Princeton, New Jersey, USA, New York, NY Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA , San Francisco, CA
Author:Robertson, Derrick Hartung, Hans-Peter Qian, Peiqing Wray, Sibyl Lee, Lily Mok, Koby Garner, Christopher Alvarez, Enrique
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.001
Author Institution:University of South Florida, Tampa, FL Heinrich Heine University Medical Faculty , Dusseldorf, Germany Swedish Medical Center, Seattle, WA Hope Neurology, Knoxville, TN TG Therapeutics, New York, NY TG Therapeutics, Seal Beach, CA University of Colorado, Aurora, CO
Author:Hartung, Hans-Peter Holmoy, Trygve Wuerfel, Jens Heer, Yanic Braune, Stefan Bergmann, Arnfin Zuercher, Mel Guye, Sabrina Kuenzel, Thomas Moore, Suzanne Vollmer, Timothy
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.005
Author Institution:Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University, Dusseldorf, Germany Akershus University Hospital, Nordbyhagen, Norway Roche PDMA Neuroscience, Basel, Switzerland PricewaterhouseCoopers AG, Zurich, Switzerland NeuroTransData, Neuburg an der Donau, Germany F. Hoffmann-La Roche Ltd., Basel, Switzerland University of Colorado, Aurora, CO
Displaying 1 - 5 of 9